United States · 
Who invested in Mineralys Therapeutics?
Mineralys Therapeutics's investors include RA Capital Management, Adams Street Partners, TCG, TCG Crossover and OrbiMed, and 3 more on record.
2026
$288MRound$500MDebt
United States · Funded startup
Who invested in Mineralys Therapeutics
Funding summaryUpdated 26 Oct 2026
$788Mraised across 2 rounds since 2025, from 2 sources
$288MRound$500MDebt
- Latest round
- Debt, $500MJun 2026
- Step-upi
- 1.7×
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $288M Sept 2025
- Biggest round
- $500M Debt · Jun 2026
- Between rounds
- 9 months from the last two
The rounds
- Jun 2026Debt$500M2 new4 returning
Source recorded
- Sept 2025Round$288M6 new
Source recorded
Founders and team
From Mineralys Therapeutics's own website and the SEC filings it signed: 7 on the team.
- Jon CongletonChief Executive Officer
- Jessica IbbitsonExecutive Vice President, Operations
- Jose BretonSenior Vice President, Finance & Controller
- Eric WarrenChief Commercial Officer
- Jeffrey MunsieChief Legal Officer
- Adam LevyChief Financial Officer
- Glenn P. SblendorioChairman
On the board, as filediAlexander AsamBrian Taylor SlingsbyDerek DiRoccoOlivier LitzkaSrinivas AkkarajuTakeshi Takahashi
AdvisersAlex Gold
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mineralys Therapeutics
How much has Mineralys Therapeutics raised?
Mineralys Therapeutics has raised $788M across 2 rounds since 2025.
When did Mineralys Therapeutics last raise?
Mineralys Therapeutics's most recent round was a Debt of $500M in Jun 2026.
What was Mineralys Therapeutics's biggest round?
Its most recent round, $500M in Jun 2026, is also its largest on record.
Who backed Mineralys Therapeutics first?
Mineralys Therapeutics's first round on record, in Sept 2025, was backed by OrbiMed, RA Capital Management and Adams Street Partners and 3 others.
What stage is Mineralys Therapeutics at?
Mineralys Therapeutics's latest named round is a Debt, in Jun 2026.
Where is Mineralys Therapeutics based?
Mineralys Therapeutics is based in the United States.
Companies like Mineralys Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.